On this week’s 51%, we look back at some of our biggest stories and favorite conversations of 2022. Following the Supreme Court’s decision to...
The Supreme Court has rejected a challenge of the Food & Drug Administration’s approval and regulation of mifepristone, preserving access to one of two...
On this week’s 51%, we speak with psychiatrist and human rights advocate Dr. Robert Okin about the state of homelessness in the U.S., and...
